| VMVAX | VMVIX | VMVAX / VMVIX | |
| Total Expense Ratio | 0.07 | 0.19 | 37% |
| Annual Report Gross Expense Ratio | 0.07 | 0.19 | 37% |
| Fund Existence | 15 years | 20 years | - |
| Gain YTD | 17.069 | 17.076 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 3000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 37.2B | 37.2B | 100% |
| Annual Yield % from dividends | 1.88 | 1.76 | 106% |
| Returns for 1 year | 22.66 | 22.67 | 100% |
| Returns for 3 years | 45.92 | 45.89 | 100% |
| Returns for 5 years | 48.54 | 48.49 | 100% |
| Returns for 10 years | 127.71 | 127.52 | 100% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFARX | 18.06 | N/A | N/A |
| Franklin Global Allocation R | |||
| FIGSX | 20.06 | N/A | N/A |
| Fidelity Series International Growth | |||
| RTSGX | 5.56 | N/A | N/A |
| Transamerica Small Cap Growth R6 | |||
| MGOCX | 33.12 | -0.17 | -0.51% |
| NYLI WMC Enduring Capital Class C | |||
| BIEMX | 18.42 | -0.47 | -2.49% |
| William Blair Emerging Mkts Growth R6 | |||